Phase I Study of GDC-0941 alone in Patients with Solid Tumors or GDC-0941 in Combination with Carboplatin / Paclitaxel + Bevacizumab in Patients with Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer.

Trial Profile

Phase I Study of GDC-0941 alone in Patients with Solid Tumors or GDC-0941 in Combination with Carboplatin / Paclitaxel + Bevacizumab in Patients with Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer.

Completed
Phase of Trial: Phase I

Latest Information Update: 27 Aug 2016

At a glance

  • Drugs Pictrelisib (Primary) ; Bevacizumab; Carboplatin; Paclitaxel
  • Indications Non-small cell lung cancer; Solid tumours
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 27 Aug 2016 Results published in the Investigational New Drugs
    • 19 Jan 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top